Clinical data | |
---|---|
Trade names | Betaseron, Actoferon, Extavia |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601151 |
License data |
|
Routes of administration | Subcutaneous |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider |
|
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard | 100.207.515 |
Chemical and physical data | |
Formula | C908H1408N246O253S6 |
Molar mass | 20011.08 g·mol−1 |
(what is this?) (verify) |
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.